First Manhattan CO Abb Vie Inc. Transaction History

First Manhattan CO

$31.9 Billion
Q3 2024

A detailed history of First Manhattan CO transactions in Abb Vie Inc. stock. As of the latest transaction made, First Manhattan CO holds 617,154 shares of ABBV stock, worth $110 Million. This represents 0.38% of its overall portfolio holdings.

Number of Shares

617,154

Previous 611,589 0.91%

Holding current value

$110 Million

Previous $105 Million 16.18%

% of portfolio

0.38%

Previous 0.35%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$163.84 - $199.33 $911,769 - $1.11 Million	5,565 Added 0.91%	617,154 $122 Million
Q2 2024 Aug 13, 2024	SELL	$154.79 - $180.76 $4.63 Million - $5.41 Million	-29,914 Reduced 4.66%	611,589 $105 Million
Q1 2024 May 15, 2024	SELL	$159.82 - $182.1 $1.37 Million - $1.56 Million	-8,564 Reduced 1.32%	641,503 $117 Million
Q4 2023 Feb 13, 2024	SELL	$137.6 - $154.97 $2.55 Million - $2.87 Million	-18,501 Reduced 2.77%	650,067 $101 Million
Q3 2023 Nov 14, 2023	SELL	$133.59 - $154.65 $29 Million - $33.5 Million	-216,897 Reduced 24.5%	668,568 $99.7 Million
Q2 2023 Aug 14, 2023	SELL	$132.51 - $164.9 $49 Million - $60.9 Million	-369,484 Reduced 29.44%	885,465 $119 Million
Q1 2023 May 15, 2023	SELL	$144.61 - $166.54 $5.56 Million - $6.4 Million	-38,417 Reduced 2.97%	1,254,949 $200 Million
Q4 2022 Feb 14, 2023	SELL	$138.31 - $165.87 $6.46 Million - $7.75 Million	-46,699 Reduced 3.48%	1,293,366 $209 Million
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $8.26 Million - $9.47 Million	-61,538 Reduced 4.39%	1,340,065 $180 Million
Q2 2022 Aug 15, 2022	SELL	$137.62 - $174.96 $9.29 Million - $11.8 Million	-67,521 Reduced 4.6%	1,401,603 $215 Million
Q1 2022 May 16, 2022	SELL	$131.98 - $163.75 $25.7 Million - $31.8 Million	-194,394 Reduced 11.69%	1,469,124 $238 Million
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $30 Million - $37.9 Million	278,874 Added 20.14%	1,663,518 $225 Million
Q3 2021 Nov 15, 2021	BUY	$106.4 - $120.78 $5.89 Million - $6.68 Million	55,311 Added 4.16%	1,384,644 $149 Million
Q2 2021 Aug 16, 2021	BUY	$105.21 - $117.21 $18.3 Million - $20.3 Million	173,554 Added 15.02%	1,329,333 $150 Million
Q1 2021 May 14, 2021	BUY	$102.3 - $112.62 $3.88 Million - $4.27 Million	37,955 Added 3.4%	1,155,779 $125 Million
Q4 2020 Feb 16, 2021	BUY	$80.49 - $108.67 $72.4 Million - $97.8 Million	899,738 Added 412.56%	1,117,824 $120 Million
Q3 2020 Nov 12, 2020	BUY	$85.91 - $100.83 $322,506 - $378,515	3,754 Added 1.75%	218,086 $19.1 Million
Q2 2020 Aug 14, 2020	SELL	$73.37 - $98.18 $46,076 - $61,657	-628 Reduced 0.29%	214,332 $21 Million
Q1 2020 May 06, 2020	BUY	$64.5 - $97.79 $13,609 - $20,633	211 Added 0.1%	214,960 $16.4 Million
Q4 2019 Feb 13, 2020	BUY	$72.13 - $90.25 $28,779 - $36,009	399 Added 0.19%	214,749 $19 Million
Q3 2019 Nov 13, 2019	BUY	$62.98 - $75.72 $2.9 Million - $3.49 Million	46,057 Added 27.37%	214,350 $16.2 Million
Q2 2019 Aug 16, 2019	BUY	$65.7 - $83.98 $11.1 Million - $14.1 Million	168,293 New	168,293 $12.2 Million
Q1 2019 Apr 12, 2019	SELL	$77.14 - $90.79 $12.7 Million - $15 Million	-164,998 Closed	0 $0
Q4 2018 Jan 30, 2019	BUY	$77.85 - $96.01 $276,523 - $341,027	3,552 Added 2.2%	164,998 $15.2 Million
Q3 2018 Oct 15, 2018	BUY	$88.91 - $98.84 $137,365 - $152,707	1,545 Added 0.97%	161,446 $15.3 Million
Q2 2018 Aug 01, 2018	SELL	$89.78 - $106.23 $11,312 - $13,384	-126 Reduced 0.08%	159,901 $14.8 Million
Q1 2018 Apr 20, 2018	BUY	$92.01 - $123.21 $7.65 Million - $10.2 Million	83,188 Added 108.26%	160,027 $15.1 Million
Q4 2017 Jan 22, 2018	SELL	$89.56 - $98.21 $17,822 - $19,543	-199 Reduced 0.26%	76,839 $7.43 Million
Q3 2017 Oct 25, 2017	BUY	$69.85 - $89.22 $5.38 Million - $6.87 Million	77,038	77,038 $6.85 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $315B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Manhattan CO, based on Form 13F filings with the SEC.

News

Stay updated on First Manhattan CO with notifications on news.

Account

First Manhattan CO Abb Vie Inc. Transaction History